医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト
ログアウト中
Login
パスワードをお忘れの場合
ログイン中
会員種別:
会員情報編集
LOGOUT
QLife Pro
ニュース・医療情報
研究報告
添付文書
医療翻訳
貴院情報
医療ボード
医学
心臓学
遺伝学
腫瘍学
眼科医療
理学療法
放射線学
外科
歯科
研究
幹細胞
バイオテクノロジー
医薬品・デバイス
製薬
臨床試験
医療機器
医療用品
疾病
AIDS
感染症
メンタルヘルス
糖尿病
医療情報
マネージド・ケア
医療管理
病院
健康
ヘルスケア
その他
その他ヘルス
ヘルス一般
獣医学
ニュース
添付文書
薬の臨床実感&助言集
NEWS
特 集
教 育
Press
Investment Bridge Announces Investment Opinion
Investment Bridge Announces Investment Opinion: Bridge Report on ZEON CORPORATION: Higher Profits Despite Lower Sales, Decrease in Both Sales and Profits This Year
ヘルスケア
医療用品
TimeLine:
and Profits This Year
Bridge Report on ZEON
Decrease in Both Sales
Higher Profits Despite Lower Sales
Investment Bridge Announces Investment Opinion
2016年10月18日
Investment Bridge Announces Investment Opinion: Bridge Report on Leopalace21 Issued: Leopalace21 Sees Strong Growth in 1st Half Profits, Estimates for Growth in Full Year Sales, Profits Remain Unchanged
ヘルスケア
マネージド・ケア
TimeLine:
Bridge Report on
Estimates for Growth in Full Year Sales
Investment Bridge Announces Investment Opinion
Leopalace21 Issued
Leopalace21 Sees Strong Growth in 1st
2015年01月05日
Investment Bridge Announces Investment Opinion: Bridge Report on R-Tech Ueno Issued: Strong Earnings Growth Recorded in FY3/14, Earnings Expected to Trend Sideways in FY3/15
その他ヘルス
ヘルスケア
眼科医療
臨床試験
製薬
TimeLine:
Bridge Report on
Earnings Expected to Trend Sideways in FY3
Investment Bridge Announces Investment Opinion
R-Tech Ueno Issued
Strong Earnings Growth Recorded in FY3
2014年08月01日
Investment Bridge Announces Investment Opinion: Bridge Report on ZEON CORPORATION Issued: Strong Earnings Growth Recorded in FY3/14, Estimates Call for Mixed Earnings in FY3/15
ヘルスケア
医療用品
TimeLine:
Bridge Report on ZEON
CORPORATION Issued
Estimates Call for Mixed Earnings in FY3
Investment Bridge Announces Investment Opinion
Strong Earnings Growth Recorded in FY3
2014年07月15日
Investment Bridge Announces Investment Opinion: Bridge Report on R-Tech Ueno Issued: Strong First Half Earnings, Full Year FY3/14 Earnings Expected to Grow Strongly
バイオテクノロジー
ヘルスケア
医療機器
眼科医療
糖尿病
製薬
TimeLine:
Earnings Expected to Grow Strongly
Full Year FY3
Investment Bridge Announces Investment Opinion
R-Tech Ueno Issued
Strong First Half Earnings
2014年01月24日
Investment Bridge Announces Investment Opinion: Bridge Report on ZEON CORPORATION: Strong First Half Earnings Results, Estimates Call for Continued Strong Growth in Full FY3/14 Earnings
ヘルスケア
医療用品
TimeLine:
Bridge Report on ZEON
Estimates Call
for Continued Strong Growth in Full FY3
Investment Bridge Announces Investment Opinion
Strong First Half Earnings Results
2014年01月09日
Investment Bridge Announces Investment Opinion: Bridge Report on ZEON CORPORATION: FY3/13 Earnings Weaker, But Estimates Call for Rise in Both Sales, Profits in FY3/14
ヘルスケア
医療用品
TimeLine:
13 Earnings Weaker
Bridge Report on ZEON
But Estimates Call for Rise
Investment Bridge Announces Investment Opinion
Profits in FY3
2013年06月21日
Investment Bridge Announces Investment Opinion: Bridge Report on R-Tech Ueno Issued: Mixed FY3/13 Earnings, Sales and Profits Expected to Grow in FY3/14
バイオテクノロジー
ヘルスケア
医療機器
眼科医療
糖尿病
製薬
TimeLine:
Bridge Report on
Expected to Grow in FY3
Investment Bridge Announces Investment Opinion
R-Tech Ueno Issued
Sales and Profits
2013年06月18日
Investment Bridge Announces Investment Opinion: Bridge Report on R-Tech Ueno Issued: Mixed First Half Earnings, Long Term Earnings Potential Remains Strong
バイオテクノロジー
ヘルスケア
医療機器
眼科医療
TimeLine:
Investment Bridge Announces Investment Opinion
Long Term Earnings
Mixed First Half Earnings
Potential Remains Strong
R-Tech Ueno Issued
2012年12月17日
Investment Bridge Announces Investment Opinion: Bridge Report on FREUND CORPORATION: First Half FY2/13 Earnings Stronger Than Expected, Full Year Estimates Call for Continued Strong Earnings Growth
ヘルスケア
製薬
TimeLine:
13 Earnings Stronger Than Expected
First Half FY2
FREUND CORPORATION
Full Year Estimates Call for Continued Strong
Investment Bridge Announces Investment Opinion
2012年11月28日
本日アクセスの多いニュース
1
オーダーメイドのがん治療ワクチン、複数のがん種で有望性示す-AACR2021報告
posted on 4月 22, 2021
2
新型コロナ濃厚接触者、基本属性・接触場所別の陽性率公表-感染研
posted on 4月 13, 2021
3
目の水晶体を透明にする、新たな細胞内分解システムを発見-東大
posted on 4月 22, 2021
4
難治性乳がん/膵がんに有効な核酸医薬候補を開発、PRDM14が標的-慶大ほか
posted on 4月 21, 2021
5
【規制改革推進会議WG】処方箋40枚ルール撤廃を-厚労省「安全前提に検討」
posted on 4月 23, 2021
Pressランキング
1
Phase 1/2 Trial Initiated for Daiichi Sankyo’s Menin Inhibitor DS-1594 in Patients with Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia
posted on 4月 7, 2021
2
PHC株式会社:薬剤師の業務効率のさらなる向上と、調剤過誤のリスク低減を目指した、自動錠剤包装機専用オプション製品 自動半錠分割機能付きタブレットケース棚「ATC-TCHC1-PJ」および半錠専用タブレットケース「TK-80HC-PJ」を発売
posted on 4月 2, 2021
3
Seagen and Astellas Announce U.S. FDA Acceptance of Two Supplemental Biologics License Applications for PADCEV® (enfortumab vedotin-ejfv) in Locally Advanced or Metastatic Urothelial Cancer
posted on 4月 19, 2021
4
世界政府峰会宣布设立“最佳部长奖特别奖”
posted on 4月 2, 2021
5
金橡医学选择Twist Bioscience为新一代精准医学检验提供动力
posted on 4月 8, 2021
6
Humanigen Reports Positive Data With Lenzilumab in the ZUMA-19 CAR-T Phase 1b Study in DLBCL and Plans to Initiate a Potential Registrational Study
posted on 4月 19, 2021
7
PTT Invests in Lotus Pharmaceutical’s Strategic Partnership in South East Asia
posted on 4月 19, 2021
8
武田召开Wave 1产品线市场电话会议
posted on 4月 2, 2021
9
LUCA Science Announces the Opening of a New Subsidiary in the UK and Expansion on the Collaboration With the University of Oxford on the Development of Novel Mitochondrial Therapeutics
posted on 4月 7, 2021
10
保诺-桑迪亚无锡新研发中心顺利完成首个制剂临床样品GMP项目生产
posted on 4月 13, 2021